This document discusses several medications used to treat hypertension during pregnancy, including labetalol, methyldopa, nifedipine, and hydralazine. Labetalol blocks alpha and beta receptors, lowering blood pressure. Its oral and intravenous doses and administration are outlined. Methyldopa is a second-line treatment and works by agonizing alpha-2 receptors; its dosing increases gradually up to 3g daily. Nifedipine is a calcium channel blocker that relaxes blood vessels and reduces heart rate, with an initial oral dose of 30mg daily that can increase to 90mg. Hydralazine causes arterial vasodilation; its intravenous administration in small, repeated doses is described.